Related Experiment Video
Updated: May 28, 2026
06:46
A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Testing relationships: ethical arguments for screening for type 2 diabetes mellitus with HbA1C
Chris Degeling1, Melanie Rock, Wendy A Rogers
1Population Health Intervention Research Centre, Calgary Institute of Population and Public Health, University of Calgary, 3280 Hospital Drive, Calgary, Alberta, Canada. cjdegeli@ucalgary.ca
Journal of Medical Ethics
|October 6, 2011
Summary
Glycated haemoglobin (HbA1C) tests are crucial for monitoring diabetes. Ethical arguments support using HbA1C for diagnosing and screening type 2 diabetes, potentially improving health equity and resource distribution.
Area of Science:
- Endocrinology
- Public Health
- Medical Ethics
Background:
- Glycated haemoglobin (HbA1C) has been the standard for diabetes mellitus (T1DM and T2DM) glycaemic control monitoring since the 1990s.
- Current discussions explore HbA1C for diabetes diagnosis and T2DM screening, focusing on individual patient benefits, cost savings, and societal advantages.
Purpose of the Study:
- To articulate the ethical justifications for HbA1C-based diagnosis and T2DM screening.
- To examine the differential impact of HbA1C testing on disadvantaged populations.
- To explore the implications of HbA1C for population health and health resource distribution.
Main Methods:
- Ethical analysis of diagnostic and screening criteria for diabetes mellitus.
- Review of current literature on HbA1C testing and its population health implications.
- Consideration of social determinants of health in the context of diabetes screening.
Main Results:
- Strong ethical arguments support HbA1C-based diagnosis and T2DM screening.
- HbA1C testing may disproportionately affect disadvantaged groups, necessitating careful ethical consideration.
- Utilizing HbA1C for diagnosis and screening can promote equitable health resource distribution.
Conclusions:
- Adopting HbA1C for diabetes diagnosis and T2DM screening offers significant ethical advantages.
- This approach can advance the understanding and mitigation of social determinants of health.
- HbA1C-based strategies may lead to a more just and equitable healthcare system for diabetes management.
Related Concept Videos
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:15Diabetes: Symptoms, Diagnosis, and Complications
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:29Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...